Business
Namaste Technologies Announces Upsize to Previously Announced Bought Deal Public Offering
Namaste Technologies Announces Upsize to Previously Announced Bought Deal Public Offering...
About this update from Lifeist Wellness Inc
[{"type":"text","content":"\n \n \n \n Namaste Technologies Announces Upsize to Previously Announced Bought Deal Public Offering\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n /NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR\n \n \n DISSEMINATION IN THE U.S./\n \n \n \n \n TORONTO\n \n ,\n \n Jan. 15, 2021\n \n /CNW/ - Namaste Technologies Inc. (\"\n \n Namaste\n \n \" or the \"\n \n Company\n \n \") (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF), a leading platform for cannabis products, accessories, and education, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. on behalf of a syndicate of underwriters (together, the \"Underwriters\") and pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 57,200,000 units (the \"Units\") in the capital of the Company at a price of\n \n C$0.35\n \n per Unit (the \"Offering Price\") for aggregate gross proceeds to the Company of\n \n C$20,020,000\n \n (the \"Offering\").\n \n \n Each Unit shall comprise of one common share (a \"Common Share\") and one common share purchase warrant (a \"Warrant\"). Each Warrant shall entitle the holder thereof to acquire one Common Share at an exercise price per Common Share of\n \n C$0.47\n \n for a period of 36 months from the Closing Date (as defined below).\n \n \n The closing of the Offering is expected to occur on or about\n \n January 19, 2021\n \n (the \"Closing Date\") and is subject to the completion of formal documentation and receipt of all regulatory approvals, including the approval of the TSX Venture Exchange.\n \n \n The net proceeds from the Offering will be used for working capital and general corporate purposes.\n \n \n The Company has granted the Underwriters an option (the \"Over-Allotment Option\"), exercisable, in whole or in part, by the Underwriters, giving notice to the Company at any time and from time to time up to 30 days following the Closing Date, to purchase, or to find substituted purchasers for, up to an additional number of Units equa...